Hepatitis B and C

被引：26
|
作者：
Karnsakul, Wikrom [1 ]
Schwarz, Kathleen B. [2 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Pediat, Pediat Liver Ctr, 600 North Wolfe St,CMSC 2-117, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, Dept Pediat, Pediat Liver Ctr, 600 North Wolfe St,CMSC 2-116, Baltimore, MD 21287 USA
来源：
PEDIATRIC CLINICS OF NORTH AMERICA | 2017年 / 64卷 / 03期
关键词：
Hepatitis B; Hepatitis C; Sustained virologic response; Pegylated interferon; Direct-acting antiviral agents; Spontaneous viral clearance; ALPHA-2B PLUS RIBAVIRIN; TO-CHILD TRANSMISSION; GENOTYPE; INFECTION; BREAST-FED INFANTS; VIRUS-INFECTION; PEGYLATED INTERFERON; HEPATOCELLULAR-CARCINOMA; UNITED-STATES; RISK-FACTORS; FOLLOW-UP;
D O I：
10.1016/j.pcl.2017.01.007
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Chronic viral hepatitis is a global health threat and financial burden. Hepatitis B and C viruses (HBV and HCV) are the most common causes of chronic viral hepatitis in the United States. Most cases are asymptomatic before adulthood. Research has resulted in effective therapy for HCV and the promise of effective therapies for HBV. For HCV, therapy is pegylated interferon and ribavirin. Clinical trials with effective direct-acting antiviral agents are underway in pediatrics. For HBV, approved agents are alpha-interferon, lamivudine, adefovir, tenofovir, and entecavir. However, treatment seldom results in functional cure and more effective therapies are urgently needed.
引用
收藏
页码：641 / +
页数：20
相关论文
共 50 条
  • [31] Efficacy and safety of alisporivir for the treatment of hepatitis C infection
    Stanciu, Carol
    Trifan, Anca
    Muzica, Cristina
    Sfarti, Catalin
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (04) : 379 - 384
  • [32] The State of Hepatitis B and C in the Mediterranean and Balkan Countries: Report from a Summit Conference
    Hatzakis, A.
    Van Damme, P.
    Alcorn, K.
    Gore, C.
    Benazzouz, M.
    Berkane, S.
    Buti, M.
    Carballo, M.
    Cortes Martins, H.
    Deuffic-Burban, S.
    Dominguez, A.
    Donoghoe, M.
    Elzouki, A-N.
    Bouafif, N. Ben-Alaya
    Esmat, G.
    Esteban, R.
    Fabri, M.
    Fenton, K.
    Goldberg, D.
    Goulis, I.
    Hadjichristodoulou, T.
    Hatzigeorgiou, T.
    Hamouda, O.
    Hasurdjiev, S.
    Hughes, S.
    Kautz, A.
    Malik, M.
    Manolakopoulos, S.
    Maticic, M.
    Papatheodoridis, G.
    Peck, R.
    Peterle, A.
    Potamitis, G.
    Prati, D.
    Roudot-Thoraval, F.
    Reic, T.
    Sharara, A.
    Shennak, M.
    Shiha, G.
    Shouval, D.
    Socan, M.
    Thomas, H.
    Thursz, M.
    Tosti, M.
    Trepo, C.
    Vince, A.
    Vounou, E.
    Wiessing, L.
    Manns, M.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 : 1 - 20
  • [33] Prevalence of hepatitis B and hepatitis C in patients with chronic schizophrenia living in institutions
    Hung, Chia-Chun
    Loh, El-Wui
    Hu, Tsung-Ming
    Chiu, Hsien-Jane
    Hsieh, Hung-Chieh
    Chan, Chin-Hong
    Lan, Tsuo-Hung
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2012, 75 (06) : 275 - 280
  • [34] Pharmacogenetics of ribavirin-induced anemia in hepatitis C
    Ampuero, Javier
    Romero-Gomez, Manuel
    PHARMACOGENOMICS, 2016, 17 (14) : 1587 - 1594
  • [35] Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006
    Walter, Scott R.
    Thein, Hla-Hla
    Amin, Janaki
    Gidding, Heather F.
    Ward, Kate
    Law, Matthew G.
    George, Jacob
    Dore, Gregory J.
    JOURNAL OF HEPATOLOGY, 2011, 54 (05) : 879 - 886
  • [36] New horizons in hepatitis B and C in the older adult
    Kemp, Linda
    Clare, Kathleen E.
    Brennan, Paul N.
    Dillon, John F.
    AGE AND AGEING, 2019, 48 (01) : 32 - 37
  • [37] Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma
    Hiotis, Spiros P.
    Rahbari, Nuh N.
    Villanueva, Gerald A.
    Klegar, Eunjie
    Luan, Wei
    Wang, Qin
    Yee, Herman T.
    BMC GASTROENTEROLOGY, 2012, 12
  • [38] Hepatitis B and C in childhood
    Gerner, P.
    Wirth, S.
    MONATSSCHRIFT KINDERHEILKUNDE, 2009, 157 (02) : 177 - 187
  • [39] IL-28B genotypes as predictors of long-term outcome in patients with hepatitis C-related severe liver injury
    Jordovic, Jelena
    Simonovic-Babic, Jasmina
    Gasic, Vladimir
    Kotur, Nikola
    Zukic, Branka
    Pavlovic, Sonja
    Lazarevic, Ivana
    Karalic, Danijela
    Katanic, Natasa
    Nikolic, Natasa
    Urosevic, Aleksandar
    Nestorov, Jelena
    Delic, Dragan
    Bojovic, Ksenija
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2019, 13 (06): : 526 - 535
  • [40] From non-A, non-B hepatitis to hepatitis C virus cure
    Pawlotsky, Jean-Michel
    Feld, Jordan J.
    Zeuzem, Stefan
    Hoofnagle, Jay H.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S87 - S99
12345